PI3Kα-IN-7
PI3Kα-IN-7 (Compound A12) is a potent PI3Kα inhibitor. PI3Kα-IN-7 also inhibits PI3Kβ. PI3Kα-IN-7 decreases cancer cells mitochondrial membrane potential and induces apoptosis[1].
Product Specifications
CAS Number
[2417098-53-2]
UNSPSC
12352005
Target
Apoptosis; PI3K
Type
Reference compound
Related Pathways
Apoptosis; PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pi3kα-in-7.html
Solubility
10 mM in DMSO
Smiles
C1(NCC2=CC(N=C(N3CCOCC3)N=C4N5CCOCC5)=C4S2)=NNC=N1
Molecular Formula
C17H22N8O2S
Molecular Weight
402.47
References & Citations
[1]Ye T, et al. Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents. Bioorg Chem. 2020 Jun;99:103796.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI3Kα; PI3Kβ
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
353544-01 48 Tests
3-NT (3-Nitrotyrosine) BioAssayTM ELISA Kit (Universal) discontinued
Ask
View Details 
353544-02 96 Tests
3-NT (3-Nitrotyrosine) BioAssayTM ELISA Kit (Universal) discontinued
Ask
View Details 373955-01 20 µg
KRT18, Recombinant, Human, aa102-396, His-Tag (Keratin, Type I Cytoskeletal 18)
Ask
View Details 
373955-02 100 µg
KRT18, Recombinant, Human, aa102-396, His-Tag (Keratin, Type I Cytoskeletal 18)
Ask
View Details 373955-03 1 mg
KRT18, Recombinant, Human, aa102-396, His-Tag (Keratin, Type I Cytoskeletal 18)
Ask
View Details